Adage Capital Partners’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-113,743
| Closed | -$223K | – | 914 |
|
|
2024
Q2 | $223K | Sell |
113,743
-366,257
| -76% | -$718K | ﹤0.01% | 822 |
|
|
2024
Q1 | $1.28M | Sell |
480,000
-462,918
| -49% | -$1.23M | ﹤0.01% | 780 |
|
|
2023
Q4 | $3.91M | Hold |
942,918
| – | – | 0.01% | 700 |
|
|
2023
Q3 | $1.3M | Hold |
942,918
| – | – | ﹤0.01% | 754 |
|
|
2023
Q2 | $2.95M | Buy |
942,918
+741,700
| +369% | +$2.32M | 0.01% | 716 |
|
|
2023
Q1 | $684K | Buy |
201,218
+121,218
| +152% | +$412K | ﹤0.01% | 813 |
|
|
2022
Q4 | $360K | Hold |
80,000
| – | – | ﹤0.01% | 868 |
|
|
2022
Q3 | $704K | Hold |
80,000
| – | – | ﹤0.01% | 904 |
|
|
2022
Q2 | $920K | Hold |
80,000
| – | – | ﹤0.01% | 926 |
|
|
2022
Q1 | $1.4M | Buy |
+80,000
| New | +$1.4M | ﹤0.01% | 922 |
|